Results 191 to 200 of about 31,394 (214)

Metabolism, excretion, and pharmacokinetics of rosuvastatin in healthy adult male volunteers

Clinical Therapeutics, 2003
Paul D Martin
exaly  

Efficacy and Safety of Ezetimibe and Rosuvastatin Combination Therapy Versus Those of Rosuvastatin Monotherapy in Patients With Primary Hypercholesterolemia

Clinical Therapeutics, 2018
Ki-Chul Sung, Min Kyu Kim, Jinho Shin
exaly  

A Phase III, Multicenter, Randomized, Double-blind, Active Comparator Clinical Trial to Compare the Efficacy and Safety of Combination Therapy With Ezetimibe and Rosuvastatin Versus Rosuvastatin Monotherapy in Patients With Hypercholesterolemia: I-ROSETTE (Ildong Rosuvastatin & Ezetimibe for Hypercholesterolemia) Randomized Controlled Trial

Clinical Therapeutics, 2018
Ki-Chul Sung, Jang-Ho Bae, Moo-Yong Rhee   +2 more
exaly  

STATIN-D Study: Comparison of the Influences of Rosuvastatin and Fluvastatin Treatment on the Levels of 25 Hydroxyvitamin D

Cardiovascular Therapeutics, 2011
Ahmet Arif Yalcin, Bunyamin Yavuz
exaly  

Rosuvastatin and risk of acute pancreatitis in a population-based case–control study

International Journal of Cardiology, 2015
Shih-Wei Lai
exaly  

Role of BCRP 421C>A polymorphism on rosuvastatin pharmacokinetics in healthy Chinese males

Clinica Chimica Acta, 2006
Zhaoqian Liu, Ya-Li Liu, Yi-Jing He
exaly  

Efficacy and safety of adding alirocumab to rosuvastatin versus adding ezetimibe or doubling the rosuvastatin dose in high cardiovascular-risk patients: The ODYSSEY OPTIONS II randomized trial

Atherosclerosis, 2016
Pjh Jones, Michel Farnier, Helen Colhoun   +2 more
exaly  

Rosuvastatin in the management of hyperlipidemia

Clinical Therapeutics, 2004
Judy W M Cheng
exaly  

Renal safety of intensive cholesterol-lowering treatment with rosuvastatin: A retrospective analysis of renal adverse events among 40,600 participants in the rosuvastatin clinical development program

Atherosclerosis, 2012
Deborah Anzalone, Donald G Vidt
exaly  

An open-label, randomized, three-way crossover trial of the effects of coadministration of rosuvastatin and fenofibrate on the pharmacokinetic properties of rosuvastatin and fenofibric acid in healthy male volunteers

Clinical Therapeutics, 2003
Paul D Martin
exaly